English
|
Spanish
Supporting oncology professionals through education
Login
Register
The content on this site is intended for healthcare professionals only
Menu
Home
News
Journal
Video
e
learning
Events
Conferences
About us
Keyword
Breast
Prostate & urology
Lung & pleura
Colorectal & gastro
Melanoma & skin
Head & neck
Ovary & gynaecology
Bone
Brain & nervous system
Haematology oncology
Hepatobiliary pancreatic
Paediatric
Neuroendocrine
Sarcomas
News
Latest news
Sign up for news alerts
Submit your news
Explore
Bone
Brain & nervous system
Breast
Colorectal & gastro
Haematology oncology
Head & neck
Hepatobiliary pancreatic
Lung & pleura
Melanoma & skin
Neuroendocrine
Ovary & gynaecology
Paediatric
Prostate & urology
Sarcomas
Journal information
Journal home
Charges
Editorial board
Founding editors
Editor-in-chief
Contact us
Author information
Submit article
Author guidelines
Editorial policies
Copyright information
Why publish with us
Reviewer information
Reviewer guidelines
Memberships
Videos
Recent videos
Sign up
Explore
Bone
Brain & nervous system
Breast
Colorectal & gastro
Haematology oncology
Head & neck
Hepatobiliary pancreatic
Lung & pleura
Melanoma & skin
Neuroendocrine
Ovary & gynaecology
Paediatric
Prostate & urology
Sarcomas
Conferences
Latest conferences
Sign up for latest coverage
Submit your event
About
e
cancer
About
e
cancer
Our founders
Funding statement
Contact us
Home
News
Journal
Video
e
learning
Events
Conferences
About us
Keyword
Breast
Prostate & urology
Lung & pleura
Colorectal & gastro
Melanoma & skin
Head & neck
Ovary & gynaecology
+
-
Bone
Brain & nervous system
Haematology oncology
Hepatobiliary pancreatic
Paediatric
Neuroendocrine
Sarcomas
Fulvestrant as treatment for advanced breast cancer
Share :
SABCS 2009
9 - 13 Sep 2009
Please rate this video
The information in this video was of interest to me
The information in this video is likely to improve my clinical practice or research
I would recommend this video to my colleagues
Published:
27 Jan 2010
Views:
8487
Rating:
Save
Rate video
Dr Angelo Di Leo - Sandro Pitigliani Medical Oncology Unit, Prato Hospital, Italy
Dr Angelo Di Leo talks about a Phase III clinical trial comparing two different doses of fulvestrant in the treatment of breast cancer.
Watch Dr Di Leo presenting his research to the official SABCS press conference.
Watch Dr Di Leo speaking about fulvestrant dose at the SABCS 2008 press conference.
Categories:
Breast
Related Videos
Pembrolizumab improves breast cancer outcomes regardless of age or menopausal...
Dr Javier Cortes - International Breast Cancer Center, Barcelona, Spain
26 Mar 2024
Exercise positively effects symptom burden and quality of life of metastatic...
Dr Anouk Hiensch - UMC Utrecht, Utrecht, Netherlands
25 Mar 2024
Using AI to identify patients at increased risk of side effects from radiation...
Dr Tim Rattay - University of Leicester Cancer Research Centre, Leicester, UK
25 Mar 2024
Implementation of the Choosing Wisely Africa List in 3 Countries
Dr Sarah Kutika Nyagabona - Muhimbili National Hospital, Dar es Salaam, Tanzania
16 Jan 2024
Adding atezolizumab to adjuvant chemotherapy for stage II and III triple...
Dr Michail Ignatiadis - Institut Jules Bordet, Brussels, Belgium
15 Jan 2024
T-DM1 shows promise in treating unresectable locally advanced or metastatic...
Dr Sara Hurvitz - University of Washington, Seattle, USA
10 Jan 2024
ASCO and its Sub-Saharan African outreach programme
Dr Julie Gralow - Chief Medical Officer, American Society of Clinical Oncology...
10 Jan 2024
CDK-4/6 inhibitors with endocrine treatment for metastatic breast cancer
Dr Sitna Mwanzi - Kenyatta National Hospital, Nairobi, Kenya
10 Jan 2024
SABCS 2023: Highlights
Dr Matteo Lambertini - San Martino Hospital, Genoa, Italy
2 Jan 2024
More from
e
cancer